Molecular Cancer (Apr 2021)
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma
- Francesca Reggiani,
- Elisabetta Sauta,
- Federica Torricelli,
- Eleonora Zanetti,
- Elena Tagliavini,
- Giacomo Santandrea,
- Giulia Gobbi,
- Giovanna Damia,
- Riccardo Bellazzi,
- Davide Ambrosetti,
- Alessia Ciarrocchi,
- Valentina Sancisi
Affiliations
- Francesca Reggiani
- Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia
- Elisabetta Sauta
- Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia
- Federica Torricelli
- Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia
- Eleonora Zanetti
- Pathology Unit, Azienda USL-IRCCS di Reggio Emilia
- Elena Tagliavini
- Pathology Unit, Azienda USL-IRCCS di Reggio Emilia
- Giacomo Santandrea
- Pathology Unit, Azienda USL-IRCCS di Reggio Emilia
- Giulia Gobbi
- Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia
- Giovanna Damia
- Laboratory of Molecular Pharmacology, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS
- Riccardo Bellazzi
- Department of Electrical, Computer and Biomedical Engineering, University of Pavia
- Davide Ambrosetti
- Department of Pharmacy and Biotechnology (FaBit), University of Bologna
- Alessia Ciarrocchi
- Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia
- Valentina Sancisi
- Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia
- DOI
- https://doi.org/10.1186/s12943-021-01357-z
- Journal volume & issue
-
Vol. 20,
no. 1
pp. 1 – 6
Abstract
No abstracts available.Keywords